PLSE (Pulse Biosciences) E10: $-1.95 (As of Mar. 2026)


PLSE Pulse Biosciences Inc PLSE
31 GF Score
Price $27.51
! 3 Warning Signs
View Full Analysis

What is Pulse Biosciences E10?

Pulse Biosciences PLSE +7.44% 31 E10 is $-1.95 as of Mar. 2026. GuruFocus rates PLSE with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pulse Biosciences's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.95 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), Pulse Biosciences's current stock price is $27.51. Pulse Biosciences's E10 for the quarter that ended in Mar. 2026 was $-1.95. Pulse Biosciences's Shiller PE Ratio of today is .


Pulse Biosciences  (NAS:PLSE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pulse Biosciences E10 Related Terms


Pulse Biosciences E10 Historical Data

* Premium members only.

The historical data trend for Pulse Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulse Biosciences E10 Chart

Pulse Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.80 -1.90

Pulse Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.84 -1.87 -1.90 -1.90 -1.95

PLSE vs NNNN, STAA, ATRC: E10 Comparison

For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulse Biosciences Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pulse Biosciences's Shiller PE Ratio falls into.


PLSE
31GF Score
Pulse Biosciences Inc PLSE
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulse Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pulse Biosciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.27/330.2130*330.2130
=-0.270

Current CPI (Mar. 2026) = 330.2130.

Pulse Biosciences Quarterly Data

per share eps CPI Adj_EPS
201606 -0.226 241.018 -0.310
201609 -0.206 241.428 -0.282
201612 -0.206 241.432 -0.282
201703 -0.226 243.801 -0.306
201706 -0.423 244.955 -0.570
201709 -0.511 246.819 -0.684
201712 -0.521 246.524 -0.698
201803 -0.501 249.554 -0.663
201806 -0.531 251.989 -0.696
201809 -0.629 252.439 -0.823
201812 -0.501 251.233 -0.658
201903 -0.482 254.202 -0.626
201906 -0.541 256.143 -0.697
201909 -0.560 256.759 -0.720
201912 -0.649 256.974 -0.834
202003 -0.560 258.115 -0.716
202006 -0.521 257.797 -0.667
202009 -0.501 260.280 -0.636
202012 -0.531 260.474 -0.673
202103 -0.698 264.877 -0.870
202106 -0.570 271.696 -0.693
202109 -0.472 274.310 -0.568
202112 -0.511 278.802 -0.605
202203 -0.570 287.504 -0.655
202206 -0.433 296.311 -0.483
202209 -0.482 296.808 -0.536
202212 -0.246 296.797 -0.274
202303 -0.256 301.836 -0.280
202306 -0.220 305.109 -0.238
202309 -0.190 307.789 -0.204
202312 -0.210 306.746 -0.226
202403 -0.180 312.332 -0.190
202406 -0.200 314.175 -0.210
202409 -0.210 315.301 -0.220
202412 -0.310 315.605 -0.324
202503 -0.250 319.799 -0.258
202506 -0.280 322.561 -0.287
202509 -0.290 324.800 -0.295
202512 -0.260 324.054 -0.265
202603 -0.270 330.213 -0.270

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-1.95 mean?
Pulse Biosciences (PLSE) has a E10 of $-1.95 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pulse Biosciences and its competitors.
Is Pulse Biosciences' E10 too high?
Pulse Biosciences' current E10 is $-1.95. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' E10 compare to NNNN and STAA?
Pulse Biosciences' E10 of $-1.95 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pulse Biosciences and its competitors. Pulse Biosciences's current E10 is $-1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current E10 of $-1.95. The current E10 is $-1.95. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current E10 is $-1.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pulse Biosciences Business Description

Other Exchanges 6L8:Germany
Address 601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score

Get the complete analysis for PLSE

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.51
Price